ACTIVE

Apotheek Bresseleers-Van der Cruyce

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result27 k €+100,1 %over 1 year

Gross margin132,1 k €+13,2 %over 1 year

Equity420,5 k €+6,9 %over 1 year

Workforce1,0 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

Apotheek Bresseleers-Van der Cruyce is a Public limited company incorporated in 1983. Its registered office is in Buggenhout. It employs on average 1,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0424.170.211
Incorporation: 25/05/1983
Legal form: Public limited company
Registered office: Kerkstraat 107
9255 Buggenhout · FlandreSee on map
Contributed capital: 62 000,00 €
Latest accounts: 31/12/2025
Average workforce: 1,0 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	132,1 k €	+13.2%	116,7 k €	-7.0%	125,5 k €	-8.0%	136,5 k €	+16.3%	117,4 k €
EBITDA	65,5 k €	+25.0%	52,4 k €	-28.9%	73,7 k €	+14.3%	64,4 k €	-16.8%	77,4 k €
Operating result	49,5 k €	+47.8%	33,5 k €	-38.9%	54,8 k €	+20.2%	45,6 k €	-23.2%	59,4 k €
Net result	27 k €	+100%	13,5 k €	-50.1%	27 k €	+25.9%	21,5 k €	-41.3%	36,6 k €
Balance sheet
Equity	420,5 k €	+6.9%	393,5 k €	+3.5%	380 k €	-16.1%	453 k €	+5.0%	431,6 k €
Total assets	509,8 k €	+10.0%	463,7 k €	-8.4%	506,2 k €	-16.8%	608,4 k €	+8.1%	562,9 k €
Cash	57,1 k €	-72.8%	210,3 k €	-14.8%	246,9 k €	-27.8%	341,9 k €	+37.6%	248,5 k €
Debts	89,3 k €	+29.5%	69 k €	-44.8%	125 k €	-19.0%	154,3 k €	+18.4%	130,3 k €
Other
Workforce	1,0 ETP	0.0%	1,0 ETP	+25.0%	0,8 ETP	-50.0%	1,6 ETP	+60.0%	1,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 8 ended

Active mandates

Ann Van der Cruyce

Managing director · since 10 janvier 2024 · until 10 janvier 2030

Active

Daniël Bresseleers

Mandate

Active

FARMAKON

Mandate · 0465.507.453

Active

Ended mandates

Ann Van Der Cruyce

Managing director · since 09 juin 2005 · until 09 juin 2011

Ended

Daniël Bresseleers

Director · since 09 juin 2005 · until 09 juin 2011

Ended

Daniël Bresseleers

Director · since 09 juin 2005 · until 06 septembre 2011

Ended

FARMAKON

Director · since 09 juin 2005 · until 09 juin 2011 · 0465.507.453

Represented by Daniël Bresseleers

Ended

Other companies at this address

Kerkstraat 107 9255 Buggenhout

Company	CBE no.
FARMAKON● Active	0465.507.453

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	18/08/2026	28/08/2025	28/08/2024	29/08/2023	26/08/2022	30/08/2021
General meeting	11/06/2026	12/06/2025	13/06/2024	08/06/2023	09/06/2022	10/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	11/06/2026	18/08/2026	Dutch	PDF
Abridged model	31/12/2024	12/06/2025	28/08/2025	Dutch	PDF
Abridged model	31/12/2023	13/06/2024	28/08/2024	Dutch	PDF
Abridged model	31/12/2022	08/06/2023	29/08/2023	Dutch	PDF
Abridged model	31/12/2021	09/06/2022	26/08/2022	Dutch	PDF
Abridged model	31/12/2020	10/06/2021	30/08/2021	Dutch	PDF
Abridged model	31/12/2019	20/08/2020	28/08/2020	Dutch	PDF
Abridged model	31/12/2018	24/06/2019	27/08/2019	Dutch	PDF
Abridged model	31/12/2017	14/06/2018	27/08/2018	Dutch	PDF
Abridged model	31/12/2016	08/06/2017	30/08/2017	Dutch	PDF
Abridged model	31/12/2015	09/06/2016	29/08/2016	Dutch	PDF
Abridged model	31/12/2014	12/06/2015	27/08/2015	Dutch	PDF
Abridged model	31/12/2013	19/06/2014	15/07/2014	Dutch	PDF
Abridged model	31/12/2012	24/06/2013	05/07/2013	Dutch	PDF
Abridged model	31/12/2011	14/06/2012	13/07/2012	Dutch	PDF
Abridged model	31/12/2010	09/06/2011	23/06/2011	Dutch	PDF
Abridged model	31/12/2009	08/06/2010	28/06/2010	Dutch	PDF
Abridged model	31/12/2008	11/06/2009	08/07/2009	Dutch	PDF
Abridged model	31/12/2007	12/06/2008	19/08/2008	Dutch	PDF
Abridged model	31/12/2006	14/06/2007	21/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 8 ended

Active mandates

Ann Van der Cruyce

Managing director · since 10 janvier 2024 · until 10 janvier 2030

Active

Daniël Bresseleers

Mandate

Active

FARMAKON

Mandate · 0465.507.453

Active

Ended mandates

Ann Van Der Cruyce

Managing director · since 09 juin 2005 · until 09 juin 2011

Ended

Daniël Bresseleers

Director · since 09 juin 2005 · until 09 juin 2011

Ended

Daniël Bresseleers

Director · since 09 juin 2005 · until 06 septembre 2011

Ended

FARMAKON

Director · since 09 juin 2005 · until 09 juin 2011 · 0465.507.453

Represented by Daniël Bresseleers

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates19/01/2024
ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates20/10/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Mandates06/01/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/11/2007
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/06/2004
ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/02/2004
ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202527 k €↑
2024
Annual accounts 202413,5 k €↓
2023
Annual accounts 202327 k €↑
2022
Annual accounts 202221,5 k €↓
2021
Annual accounts 202136,6 k €↑
2019
Annual accounts 20196,1 k €↓
2018
Annual accounts 201839,4 k €↑
2017
Annual accounts 2017-50,1 k €↓
2016
Annual accounts 201657,9 k €↑
2015
Annual accounts 201552,2 k €↑
2014
Annual accounts 201433,5 k €↓
2013
Annual accounts 201368,1 k €↑
2012
Annual accounts 201224,4 k €↓
2011
Annual accounts 201170,5 k €↓
2010
Annual accounts 201081,3 k €↓
2009
Annual accounts 200989 k €↑
2008
Annual accounts 200877,8 k €↓
2007
Annual accounts 200791,6 k €↑
2006
Annual accounts 200659,9 k €
25/05/1983
IncorporationPublic limited company

Apotheek Bresseleers-Van der Cruyce

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline